[1]
|
International Diabetes Federation (2011) IDF Diabetes Atlas. 5th Edition, International Diabetes Federation, Brussels.
|
[2]
|
Balla, S.A., Abdalla, A.A., Elmukashfi, T.A. and Ahmed, H.A. (2014) Hypertension among Rural Population in Four States: Sudan 2012. Global Journal of Health Science, 6, 206. http://dx.doi.org/10.5539/gjhs.v6n3p206
|
[3]
|
Muninarayana, C., Balachandra, G., Hiremath, S., Iyengar, K. and Anil, N. (2010) Prevalence and Awareness Regarding Diabetes Mellitus in Rural Tamaka, Kolar. International Journal of Diabetes in Developing Countries, 30, 18. http://dx.doi.org/10.4103/0973-3930.60005
|
[4]
|
Tesfaye, S. and Gill, G. (2011) Chronic Diabetes Complications in Africa. African Journal of Diabetes Medicine, 19.
|
[5]
|
Frank, R. (2004) Diabetic Retinopathy. New England Journal of Medicine, 350, 48-58. http://dx.doi.org/10.1056/NEJMra021678
|
[6]
|
Mbanya, J.C. and Sobngwi, E. (2003) Diabetes in Africa. Diabetes Microvascular and Macrovascular Disease in Africa. Journal of Cardiovascular Risk, 2, 97-102. http://dx.doi.org/10.1177/174182670301000204
|
[7]
|
Noubiap, J.J.N., Naidoo, J. and Kengne, A.P. (2015) Diabetic Nephropathy in Africa: A Systematic Review. World Journal of Diabetes, 6, 759-773. http://dx.doi.org/10.4239/wjd.v6.i5.759
|
[8]
|
Kengne, A.P., Sobngwi, E., Echouffo-Tcheugui, J.B. and Mbanya, J.C. (2013) New Insights on Diabetes Mellitus and Obesity in Africa—Part 2: Prevention, Screening and Economic Burden. Heart, 99, 1072-1077. http://dx.doi.org/10.1136/heartjnl-2013-303773
|
[9]
|
Mbanya, J.C., Motala, A.A., Sobngwi, E., Assah, F.K. and Enoru, S.T. (2010) Diabetes in Sub-Saharan Africa. Lancet, 375, 2254-2266. http://dx.doi.org/10.1016/S0140-6736(10)60550-8
|
[10]
|
Fahal, I.H. (2009) The Diabetic Kidney—“A Systematic, Diabetes Renal Service, Better for Patients and Clinicians”. Sudan Medical Journal, 45.
|
[11]
|
Parving, H.-H. (1996) Initiation and Progression of Diabetic Nephropathy. New England Journal of Medicine, 335, 1682-1683. http://dx.doi.org/10.1056/NEJM199611283352212
|
[12]
|
Andersen, A.R., Sandahl Christiansen, J., Andersen, J.K., Kreiner, S. and Deckert, T. (1983) Diabetic Nephropathy in Type-1 (Insulin-Dependent) Diabetes: An Epidemiological Study. Diabetologia, 25, 496-501. http://dx.doi.org/10.1007/BF00284458
|
[13]
|
DeFronzo, R.A. (1995) Diabetic Nephropathy: Etiologic and Therapeutic Considerations. Diabetes Reviews, 3, 510-564.
|
[14]
|
Razmaria, A.A. (2015) Diabetic Neuropathy. JAMA, 314, 2202. http://dx.doi.org/10.1001/jama.2015.15899
|
[15]
|
Tesfaye, S., Stevens, L., Stephenson, J., et al., on Behalf of the EURODIAB IDDM Study Group (1996) The Prevalence of Diabetic Neuropathy and Its Relation to Glycaemic Control and Potential Risk Factors: The EURODIAB IDDM Complications Study. Diabetologia, 39, 1377-1384. http://dx.doi.org/10.1007/s001250050586
|
[16]
|
Boulton, A.J., Malik, R.A., Arezzo, J.C. and Sosenko, J.M. (2004) Diabetic Somatic Neuropathies. Diabetes Care, 27, 1458-1486. http://dx.doi.org/10.2337/diacare.27.6.1458
|
[17]
|
Dyck, P.J., Kratz, K.M., Karnes, J.L., et al. (1993) The Prevalence by Staged Severity of Various Types of Diabetic Neuropathy, Retinopathy, and Nephropathy in a Population-Based Cohort: The Rochester Diabetic Neuropathy Study. Neurology, 43, 817-824. http://dx.doi.org/10.1212/WNL.43.4.817
|
[18]
|
Bos, M. and Agyemang, C. (2013) Prevalence and Complications of Diabetes Mellitus in Northern Africa, a Systematic Review. BMC Public Health, 13, 387. http://dx.doi.org/10.1186/1471-2458-13-387
|
[19]
|
Palmer, J.P., Fleming, G.A., Greenbaum, C.J., et al. (2004) C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve Beta-Cell Function: Report of an ADA Workshop, 21-22 October 2001. Diabetes, 53, 250-264.
|
[20]
|
Marques, R.G., Fontaine, M.J. and Rogers, J. (2004) C-Peptide: Much More than a Byproduct of Insulin Biosynthesis. Pancreas, 29, 231-238. http://dx.doi.org/10.1097/00006676-200410000-00009
|
[21]
|
Gross, J.L., de Azevedo, M.J., Silveiro, S.P., Canani, L.H., Caramori, M.L. and Zelmanovitz, T. (2005) Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care, 28, 164-176.
|
[22]
|
Sari, R. and Balci, M.K. (2005) Relationship between C Peptide and Chronic Complications in Type-2 Diabetes Mellitus. Journal of the National Medical Association, 97, 1113-1118.
|
[23]
|
Lev-Ran, A., Hwang, D., Barseghian, G. and Hill, L.R. (1986) Control of Noninsulin Dependent Diabetes Is Not Correlated with Endogenous Insulin Secretion. Diabetes & Metabolism, 12, 325-328.
|
[24]
|
Johansson, J., Ekberg, K., Shafqat, J., et al. (2002) Molecular Effects of Proinsulin C-Peptide. Biochemical and Biophysical Research Communications, 295, 1035-1040. http://dx.doi.org/10.1016/S0006-291X(02)00721-0
|
[25]
|
Hills, C.E., Brunskill, N.J. and Squires, P.E. (2010) C-Peptide as a Therapeutic Tool in Diabetic Nephropathy. American Journal of Nephrology, 31, 389-397. http://dx.doi.org/10.1159/000289864
|
[26]
|
Mughal, R.S., Scragg, J.L., Lister, P., et al. (2010) Cellular Mechanisms by Which Proinsulin C-Peptide Prevents Insulin-Induced Neointima Formation in Human Saphenous Vein. Diabetologia, 53, 1761-1771. http://dx.doi.org/10.1007/s00125-010-1736-6
|
[27]
|
Michaud, D.S., Wolpin, B., Giovannucci, E., Liu, S., Cochrane, B., Manson, J.E., Pollak, M.N., Ma, J. and Fuchs, C.S. (2007) Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women. Cancer Epidemiology, Biomarkers & Prevention, 16, 2101. http://dx.doi.org/10.1158/1055-9965.EPI-07-0182
|
[28]
|
Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J.M. and Stampfer, M.J. (2004) A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men. Journal of the National Cancer Institute, 96, 546-553. http://dx.doi.org/10.1093/jnci/djh082
|
[29]
|
Patel, N., Taveira, T.H., Choudhary, G., Whitlatch, H. and Wu, W.-C. (2012) Fasting Serum C-Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults. Journal of the American Heart Association, 1, e003152. http://dx.doi.org/10.1161/jaha.112.003152
|
[30]
|
Elmahdi, E.M., Kaballo, A.M. and Mukhtar, E.A. (1991) Features of Non-Insulin-Dependent Diabetes Mellitus (NIDDM) in the Sudan. Diabetes Research and Clinical Practice, 11, 59-63. http://dx.doi.org/10.1016/0168-8227(91)90142-Z
|
[31]
|
Mosier, M.A. (1984) Circulating C Peptide and Diabetic Retinopathy. Diabetes Research, 1, 151-154.
|
[32]
|
Suzuki, K., Watanabe, K., Motegi, T. and Kajinuma, H. (1989) High Prevalence of Proliferative Retinopathy in Diabetic Patients with Low Pancreatic B-Cell Capacity. Diabetes Research and Clinical Practice, 6, 45-52. http://dx.doi.org/10.1016/0168-8227(89)90056-9
|
[33]
|
Inukai, T., Matsutoma, R., Tayama, K., Aso, Y. and Takemura, Y. (1999) Relation between the Serum Level of C Peptide and Risk Factors for Coronary Heart Disease and Diabetic Microangiopathy in Patients with Type-2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes, 107, 40-45. http://dx.doi.org/10.1055/s-0029-1212071
|
[34]
|
Madsbad, S., Laurtzen, E., Faber, O.K. and Binder, C. (1986) The Effect of Residual Beta-Cell Function on the Development of Diabetic Retinopathy. Diabetic Medicine, 3, 42-45. http://dx.doi.org/10.1111/j.1464-5491.1986.tb00704.x
|
[35]
|
Kim, B.-Y., Jung, C.-H., Mok, J.-O., Kang, S.-K. and Kim, C.-H. (2012) Association between Serum C-Peptide Levels and Chronic Microvascular Complications in Korean Type 2 Diabetic Patients. Acta Diabetologica, 49, 9-15. http://dx.doi.org/10.1007/s00592-010-0249-6
|
[36]
|
Nilsson, P., Lundgren, H., Söderström, M., Fagerström, K.O. and Nilsson-Ehle, P. (1996) Effects of Smoking Cessation on Insulin and Cardiovascular Risk Factors—A Controlled Study of 4 Months’ Duration. Journal of Internal Medicine, 240, 189-194. http://dx.doi.org/10.1046/j.1365-2796.1996.16844000.x
|